Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.45 | 49.20 |
| PEG Ratio (TTM) | 0.07 | 4.47 |
| P/S Ratio (TTM) | 5.45 | 3.91 |
| P/B Ratio (TTM) | 23.26 | 6.59 |
| P/FCF Ratio (TTM) | -3.13 | 42.56 |
| Price to 5YR AVG Earnings Ratio | N/A | 44.77 |
| Price to 5YR AVG FCF Ratio | N/A | 58.19 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -59.85% | 4.59% |
| ROE (TTM) | -180.10% | 17.50% |
| Net Profit Margin (TTM) | -223.03% | 8.08% |
| ROIC 5YR AVG | N/A | 10.48% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -31.19% | 1.71% | N/A |
| Revenue | -4.68% | 51.04% | N/A |
| Net Income | -31.48% | -25.12% | N/A |
| Cash Flow | -36.12% | -9,317.21% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.91 | 0.87 |
| Quick Ratio (TTM) | 2.91 | 0.83 |
| D/E Ratio (TTM) | 2.12 | 1.49 |
| Interest Coverage (TTM) | N/A | 5.32 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 3.01 |
| LTL to 5YR AVG FCF | N/A | 17.92 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.28% |